x

Posted 08 September, 2022

CARDINAL HEALTH INC appointed new CEO

CEO Change detected for ticker NYSE:CAH in a 8-K filed on 08 September, 2022.


  On September 8, 2022, Cardinal Health, Inc. (the "Company") announced that Victor L. Crawford will cease to serve as Chief Executive Officer, Pharmaceutical Segment effective September 19, 2022.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of CARDINAL HEALTH INC
Retail/Wholesale • Drug Retail
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Market Cap
$27.4B
View Company Details
CARDINAL HEALTH INC by TradingView
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 


On September 8, 2022, Cardinal Health, Inc. (the "Company") announced that Victor L. Crawford will cease to serve as Chief Executive Officer, Pharmaceutical Segment effective September 19, 2022. Mr. Crawford will remain with the Company through November 13, 2022 to help with the transition of the role to his replacement. The Board of Directors of the Company has determined that Mr. Crawford's departure from the Company will entitle him to severance benefits as an involuntary termination without cause under the Cardinal Health, Inc. Senior Executive Severance Plan (as amended, the "Severance Plan") following his departure date. Receipt of these severance benefits is subject to the terms of the Severance Plan, including the required execution of a general release and compliance with certain restrictive covenants. The Severance Plan is filed as Exhibits 10.7.1 and 10.7.2 to the Company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on August 11, 2022.